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1. Introduction  
Colonoscopy plays an important role in the medical care of patients with colorectal cancer. It 
is generally used for both the diagnosis of different stages of colorectal cancer and the 
treatment of early colorectal cancer and its precursors. The recent progress in colonoscopy 
has been remarkable. Endoscopes with variable rigidity and small diameters provide 
efficient insertion to the cecum and result in lower distress for patients. Trained 
colonoscopists can insert endoscopes into the cecum within a few minutes, and it is not 
necessary to anesthetize patients without severe peritoneal adhesion.  
We can obtain good-quality pictures and special images to assist in diagnosis by using high-
vision endoscopes, magnifying endoscopes, dye spray, and narrow-band imaging (NBI). 
Determining whether a colorectal carcinoma can be curatively resected by endoscopic 
treatment or whether the carcinoma has a risk of lymph node metastasis is a very delicate 
and important task. In particular, the depth of cancer invasion is related to lymph node 
metastasis; therefore, endoscopic ultrasonography and the classification of pit patterns, 
capillary patterns via NBI, and the lesion-lifted condition are used to diagnose the depth of 
cancer invasion (Kato, 2001, Sano, 2008). 
Treatment for colorectal neoplastic lesions begins with hot biopsy and snare polypectomy, 
and recently, endoscopic submucosal resection (EMR), piecemeal EMR (EPMR), and 
endoscopic submucosal dissection (ESD) have become available for large and flat lesions of 
the colon and rectum. Early colorectal carcinoma is defined as a carcinoma within the 
submucosal layer that is not invading the muscularis propria. Carcinoma in situ (mucosal 
carcinoma) and carcinoma that slightly invades the submucosa and without risk factors 
for metastasis do not metastasize into lymph nodes or distant organs. Nonmetastatic 
carcinoma is cured by local resection with colonoscope. It is important to make an 
accurate diagnosis by endoscopy and to perform confident resection for pathological 
evaluation. 
In this chapter, we describe endoscopic diagnosis for colorectal carcinoma and differential 
diagnosis, and treatment options for early colorectal cancer without metastasis and for 
adenoma which is regarded as a precancerous condition. In addition, we briefly discuss risk 
factors for lymph node metastasis in early colorectal carcinoma.  
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2. Endoscopic diagnosis of colorectal carcinoma  
Colorectal carcinomas are the most common malignancies in industrialized countries, and 
are classified as early or advanced according to the depth of invasion. In advanced cancers, 
the invasion reaches the muscularis propria (MP) or the deeper layers. In endoscopic 
diagnosis, macroscopic classification is the most basic information. In this section, 
endoscopic diagnosis of colon carcinoma is discussed.  
2.1 Macroscopic classification of colorectal carcinoma 
Colonoscopy is a valuable tool in the diagnosis and management of colorectal neoplasms. 
Advanced colorectal carcinoma can be divided into 4 groups based on endoscopic 
appearances (Fig. 1).  
 
Type 1 Type 2 Type 3 Type 4 
    
 
Fig. 1. Macroscopic types of advanced colorectal carcinoma 
 
Type 1 Type 2 Type 3 Type 4 
Type 1 lesion, protuberant tumor with fold convergence 
Type 2 lesion, showing an irregular ulceration and clear marginal swelling 
Type 3 lesion, showing an irregular ulceration and unclear marginal swelling 
Type 4 lesion, showing an irregularly edematous mucosa with luminal stenosis due to diffuse 
infiltration, Ulceration is not pointed out on the lesion. 
Fig. 2. Endoscopic view of each type of advanced colorectal carcinoma  
Localized carcinoma is classified as a polypoid- (protuberant type) or ulcerative–type lesion. 
More than 90% of colorectal carcinomas are ulcerative-type lesions. To further distinguish 
early colorectal carcinoma and unclassified advanced colorectal carcinoma, the macroscopic 
type is subclassified from Type 0 to Type 5 (Sugihara, 2009). Early cancers are defined by the 
depth of cancer invasion into mucosal or submucosal layers. In this manual, early carcinoma 
is classified as Type 0, and advanced carcinoma is classified as Type 1 to 5.  
The subclassification of Type 0 carcinoma is described in further detail in the next section. 
Type 1 lesions are protuberant. Type 2 lesions include ulcerative-type lesions with clear 
margins, and Type 3 lesions include ulcerative-type lesions with infiltration. Diffusely 
infiltrating lesions are classified as Type 4 lesions (Fig. 2). Type 5 lesions are an unclassified 
type. Type 2 is the most common type of advanced colorectal carcinoma. Circular carcinoma 
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of Type 2 is occasionally observed as a stenosis due to the tumor of the large intestine, and 
ulceration is not always detected by endoscopy. Pathological examination of biopsy 
specimen from the stenosis or edge of ulceration reveals adenocarcinoma. Type 4 lesion is 
observed like hard mucosal stenosis and neither obvious tumor nor ulceration is always 
recognized by endoscopy. And pathological diagnosis from biopsy is very difficult because 
the carcinoma is covered with normal mucosa.    
2.2 Early colorectal carcinoma  
Early colorectal carcinoma is defined as a carcinoma that is confined to the mucosa (M) and 
submucosa (SM). Early colon carcinoma may occur in an adenomatous polyp or may be 
difficult to distinguish from a nonmalignant adenomatous polyp by colonoscopy. For 
example, a 2-cm-wide villous adenoma has an approximately 40% chance of harboring 
cancer (Kim, 1997). Polyp risk factors for malignancy include villous rather than tubular 
histology, large size, sessile morphology, and high numbers of colonic polyps (Morson, 
1972). Another route of carcinogenesis is “de novo” carcinogenesis, which produces small, 
aggressive carcinomas that do not appear to develop from adenomas (Kudo, 1997; Mueller, 
2002). Macroscopic depressed type is the most common type of this carcinoma. This type is 
difficult to diagnose early using colonoscopy let alone barium enema; therefore, it is 
important to observe these lesions by endoscope extremely carefully. Early colorectal 
carcinoma is asymptomatic. It is usually revealed by screening colonoscopy or a positive 
stool occult blood test followed by colonoscopy. Colorectal screenings are important for 
detecting early colorectal carcinoma, which may be curatively treated by endoscopy.  
2.2.1 Macroscopic type of early colorectal carcinoma 
Regarding the classification of macroscopic-type lesions, the Japanese colorectal cancer 
handling protocol and Paris classification are representative classification systems. Both are 
used to judge endoscopic findings. Early colorectal carcinoma is classified as any Type 0 
lesion judged to be a superficial carcinoma. 
2.2.2 Japanese classification of colorectal carcinoma 
Type 0 is subclassified into Type 0-I (tubercle type) and 0-II (surface type). Type 0-I is 
further subclassified as Ip (pedunculated), Isp (subpedunculated), and Is (sessile), whereas 
Type 0-II is further subclassified as IIa (surface tubercle), IIb (surface flatness), and IIc 
(surface depressed) (Fig. 3). 
 
 
Fig. 3. Classification of superficial colorectal carcinoma (Japanese protocol) 
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Carcinomas can also be mixed-type lesions, which are lesions possessing elements of both 
Type 0-I and 0-II. Mixed-type lesions include types 0-IIc+IIa, 0-IIa+IIc, 0-IIc+Is, and 0-Is+IIc.  
2.2.3 Paris classification 
Terms used in the Paris classification of macroscopic-type lesions are unified by the terms 
used in a paper by Schlemper in 2002 (Fig. 4).  
 
 
Fig. 4. Paris classification of superficial colorectal carcinoma  
Firstly, lesions are divided into polypoid (Type 0-I) and non-polypoid (Type 0-IIa, IIb, IIc) 
lesions, and Type 0-I is subclassified as Type 0-Ip (pedunculated) and Type 0-Is (sessile). 
Type 0-III carcinomas comprise excavated-type lesions in the original classification, but 
these lesions are rare in the colon and rectum. Isp lesions are classified in the Japanese 
colorectal carcinoma handling protocol as Type 0-Is. Type 0-IIa lesions include those in 
which their height does not exceed that of closed biopsy forceps (about 2.5 mm), and lesions 
with heights exceeding this threshold are classified as type0-Is. Mixed-type lesions include 
Type 0-IIa+IIc, 0-IIc+IIa, 0-IIc+Is, and 0-Is+IIc (Fig. 5,6). 
 
 
Fig. 5. Classification of mixed-type lesions (Paris classification) 
www.intechopen.com
 Endoscopic Diagnosis and Treatment for Colorectal Cancer 331 
Type 0-IIc (A) (B) Type 0-IIa+IIc (C) (D) 
Fig. 6. (A) Type 0-IIc, Ordinary colonoscopic picture showing a depressed area with erosion 
(B) Type 0-IIc, Indigocarmine dye spraying view (C) Type 0-IIa+IIc, Ordinary colonoscopic 
picture showing a flat elevated lesion with irregular depressed area (D) Type 0-IIa+IIc, 
Indigocarmine dye spraying view 
The importance of an endoscopic classification system for superficial lesions is that it 
permits endoscopic staging. In other words, we can predict the depth of invasion of a 
superficial carcinoma and predict the risk of lymph node metastasis, both of which assist in 
treatment selection (endoscopic treatment or surgical resection). Regarding Type 0-I lesions, 
if a lesion becomes large size, the risk of submucosal invasion is increased gradually. 
Conversely, Type 0-IIc lesions have deep invasion tendencies despite their small size. In 
addition, Type 0-IIa+IIc lesions frequently infiltrate the deep stratum submucosum, and 
their potential for progression is higher than that of other types. 
2.3 Endoscopic ultrasonography (EUS) and diagnosis of depth invasion for colorectal 
carcinoma 
EUS is an imaging technique for ultrasound scanning of the gastrointestinal tract lumen. It 
can depict lesions as vertical tomographic images. EUS can be used to evaluate the depth of 
invasion of epithelial tumors and carcinomas, as well as for qualitative diagnosis, such as 
the differential diagnosis of extramural lesions in patients with submucosal tumors. EUS is 
an important diagnostic procedure for deciding the treatment policy and assessing the 
status of diseases involving the lower gastrointestinal tract. This section focuses on the 
diagnosis of colorectal cancer. 
The lower gastrointestinal tract has the highest incidence of colorectal cancer; EUS is 
indicated for the diagnosis of the depth of wall invasion and lymph node metastases. EUS is 
also indicated for the evaluation of submucosal tumors. Malignant lymphomas, 
gastrointestinal stromal tumors (GIST), lymphangiomas, and lipomas arise at a relatively 
high frequency in the lower gastrointestinal tract.  
2.3.1 Instruments and ultrasonic probe (USP) of EUS 
Ultrasonographic instruments specifically for the colorectum and ultrasonic probes are 
available for EUS of the colorectal region. Endoscopic three-dimensional ultrasonic probes 
are also commercially available.  
An ultrasonic probe is attached to the tip of a direct-viewing electronic endoscope to 
perform mechanical radial ultrasonic scanning. One advantage of using a specialized device 
is the excellent ultrasonic resolution, allowing distinct tomographic images to be obtained 
throughout the entire intestine. Scanning can be performed at either of two frequencies (7.5 
MHz, 20 MHz), and the frequency best suited for a given lesion can be selected. The higher 
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frequency is better suited for low and superficial lesions, whereas the lower frequency is 
recommended for the assessment of high and deep lesions  and the examination of lymph 
node metastases and other lesions around the intestine. A disadvantage of specialized 
devices is the large outer diameter of the scope and the long hard tip, often precluding 
insertion into the proximal side of the sigmoid colon. 
A USP can usually be inserted in the forceps channel of the endoscope. Either a 12-, 20-, or 
30-MHz probe is selected, depending on the lesion. A USP is inferior to a specialized device 
in terms of lateral resolution and durability, but excels with respect to targeting because 
ultrasonic procedures can be done while directly viewing a lesion. Lesions associated with 
stenosis are also good indications for a USP. 
2.3.2 Diagnostic technique of EUS for colorectal carcinoma 
The colorectal wall is fundamentally depicted as a 5-layer structure on EUS. Starting from 
the lumen, the first, hyperechoic layer and the second, hypoechoic layer correspond to the 
mucosa, the third, hyperechoic layer to the submucosa, the fourth, hypoechoic layer to the 
muscularis propria, and the fifth, hyperechoic layer to the sabserosa and serosa (the tunica 
adventitia at sites with no serosa) (Fig. 7.).  
 
 
Fig. 7. Layer structure of the normal intestinal wall 
With the use of high-frequency devices (20-30 MHz), the muscularis mucosae is depicted as 
a thin hypoechoic layer with a hyperechoic border at the upper margin of the third layer. In 
the fourth layer, the connective tissue of the muscularis is depicted as a thin hyperechoic 
layer, and the colorectal wall is sometimes depicted as a 9-layer structure. An understanding 
of these characteristics is essential for the diagnosis of lesions by comparison with the layer 
structure of the intestinal wall.  
2.3.3 Diagnosis of colorectal carcinoma on EUS 
On EUS, the depth of wall invasion is evaluated on the basis of what layers are preserved or 
destroyed by a hypoechoic mass. In M cancer (intramucosal cancer), the mass is confined to 
the first to second layers. In SM cancer (cancer invading the submucosa), the third layer is 
narrowed or ruptured by the mass, but the fourth layer remains intact. In MP cancer (cancer 
invading the muscularis propria), the fourth layer is narrowed or ruptured by the mass, but 
the fifth layer remains intact (Fig. 8.). 
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               (A)                                           (B)                                     (C)
Fig. 8. Endoscopic view and EUS image, (A) Mucosal cancer, (B) SM cancer, (C)MP cancer 
In SS to SE cancer (cancer invading the sabserosa or serosa) or A cancer (cancer invading the 
tunica adventitia), the fifth layer is narrowed or ruptured by the mass, but the border with 
the adjacent organ remains intact. In SI or AI cancer (cancer invading the adjacent organ), up 
to the fifth layer is destroyed by the mass, and the border with the adjacent organ is 
unclearly demarcated.   
2.3.4 Diagnosis of invasion depth of SM cancer 
Intramucosal cancer and SM cancer with mild invasion to a vertical depth of less than 1000 
µm from the lower border of the muscularis mucosae have virtually no risk of metastasis, 
and cure can be expected after endoscopic treatment. Endoscopic therapy is thus indicated 
for such lesions (Sugihara, 2009). On EUS, SM cancers are classified into lesions with 
shallow invasion and those with deep invasion at the time of diagnosis based on Kudo’s 
classification of SM cancer (Kudo, 2000). The third layer, corresponding to the normal 
submucosa adjacent to cancer, is subdivided into 3 equal layers, and the location of deepest 
region of the hypoechoic mass is determined. Masses that are confined to the shallowest 
third of the submucosa are classified as sm1, those that invade the second third are classified 
as sm2, and those that invade deeper than the second third, but do not extend beyond the 
region near the medial border of the fourth layer are classified as sm3. SM cancers with 
shallow invasion correspond to sm1, and those with deep invasion correspond to sm2 and 
sm3. EUS diagnosis thus plays an important role in the selection of treatment for early 
colorectal cancer.  
2.3.5 Diagnosis of lymph node metastasis  
Normal lymph nodes are not depicted on EUS. Lymph nodes visualized on EUS that have a 
shortest diameter of ≥5 mm, a hyperechoic and homogeneous internal echo, and are either 
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circular or irregularly shaped are considered positive for metastasis. However, differential 
diagnosis from enlarged lymph nodes associated with inflammation is challenging. The rate 
of correctly diagnosing lymph node metastases has been reported to be 70% to 80% (Tio, 
1991, Cho E, et al. 1993). The diagnostic ability of EUS is thus not considered good.  
EUS is useful for diagnosis of the invasion depth of colorectal cancer because it can depict 
lesions as vertical tomographic images. It is thus an important diagnostic procedure for 
deciding treatment policy and evaluating disease status.  
2.4 Diagnosis of colorectal neoplastic lesions by chromoendoscopy and image-
enhanced endoscopy 
If a colorectal lesion is detected by conventional endoscopy, the location, size, macroscopic 
type, color, surface pattern, presence of fold conversion, and air-induced deformation can be 
observed. The indigo carmine dye-spraying method more clearly reveals the extent and 
surface pattern. In addition, magnifying endoscopy after staining with indigo carmine or 
crystal violet is useful for pit pattern classification (Kudo et al., 1994), as it enables the 
differentiation of neoplasms as well as histological grading and depth evaluation of early 
cancers. This leads to the selection of endoscopic therapy or surgery.  
The combination of image-enhanced endoscopic techniques such as NBI with magnification 
is used to observe the capillary pattern of the tumor surface, and these techniques can also 
improve diagnosis (Sano et al., 2006). 
2.4.1 Classification of pit pattern  
Pit patterns in the large intestine were classified into 7 types by Kudo (Fig. 9). Type I 
includes round pits that are observed in normal mucosa. Type II includes stellar or papillary 
pits, and these pits always indicate hyperplasia. Type IIIs includes small tubular or  
round pit that are smaller than normal pits, and they indicate neoplastic lesions, 
occasionally including carcinoma that can be resected by endoscopy. Type IIIL includes  
 
 
Type I Type II Type IIIs Type IIIL 
          Type IV             Type VI                            Type VN 
Fig. 9. Classification of pit pattern 
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tubular or roundish pits that are larger than normal pits. Almost all of Type IIIL lesions are 
tubular adenomas in pathology, which can be treated by polypectomy. Type IV includes 
branch-like or gyrus-like pits, most of which are tubulovillous adenoma. Mucosal carcinoma 
is present in 35% of these pits and can be treated by endoscopy. Type VI includes irregularly 
arranged pits that may be submucosal invasive carcinoma, for which the proper treatment 
straddles the borderline between endoscopic and surgical therapy. Lastly, type VN includes 
nonstructured pits, which indicate massive submucosal invasive carcinoma and require 
surgical resection with lymph node dissection.  
Kudo reported that small round pit patterns (type IIIs) and non-pit patterns (type V) were 
common in depressed lesions and that these depressed lesions had invaded the deeper 
layers more rapidly than had protruding lesions.  
2.4.2 Classification of capillary pattern by magnified NBI  
The NBI system involves modifying spectral features by narrowing the bandwidth of 
spectral transmittance using various optical filters (Sano, 2001). This modification provides a 
unique image that emphasizes the capillary pattern, as well as the surface structure, by 
simple operation of a button on the control panel of the endoscope. Because of its similarity 
to chromoendoscopy, NBI can be referred to as optical or digital chromoendoscopy. Sano et 
al. (2006) classified 3 types and names (CP types I, II, and III) of microvascular architectures 
based on the magnified NBI pattern. CP type I has no meshed capillary vessels. CP type II 
has meshed capillary vessels surrounding the mucosal glands. CP type III lesions were 
further classified into 2 groups: types IIIA and IIIB. CP type IIIA has irregular meshed 
capillary vessels, whereas irregular meshed capillary vessels disappear or loosen in CP type 
IIIB (Fig.10). CP types I, II, IIIA, and IIIB are observed in nonneoplastic lesions, adenomas, 
mucosal or slightly invasive submucosal carcinoma, and massive invasive submucosal 
carcinoma, respectively. Capillary patterns, as assessed by magnifying NBI, are useful for 
differentiating small colorectal nonneoplastic polyps from neoplastic ones (accuracy, 95.3%; 
sensitivity, 96.4%; and specificity, 92.3%) (Sano, 2008), and they are highly accurate for 
distinguishing low-grade dysplasia from high-grade dysplasia/invasive cancer (accuracy, 
95.5%; sensitivity, 90.3%; and specificity, 97.1%) (Katagiri, 2008). Therefore, capillary 
patterns can be used to predict the histopathology of colorectal neoplasia.  
 
 
CP type I CP type II CP type IIIA CP type IIIB 
Fig. 10. Capillary pattern by magnified NBI 
2.5 Risk factor for lymph node metastasis of submucosal invasive carcinoma  
Lymph node metastasis is reported to occur in approximately 10% of SM cancers. SM cancer 
is a boundary lesion, and its treatment plan involves endoscopic treatment or surgical 
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resection with lymph node dissection. Therefore, investigation of the risk factors for lymph 
node metastasis is important. The risk factors for lymph node metastasis are described on 
the “Colorectal Cancer Treatment Guideline 2009,” written by the Japanese Society for 
Cancer of the Colon and Rectum; these guidelines are listed below. When a risk factor for 
metastasis is revealed upon examination of an endoscopically resected SM cancer specimen, 
additional surgical resection with lymph node dissection is recommended. 
1. Carcinoma that is histologically classified as poorly differentiated adenocarcinoma, 
signet ring cell adenocarcinoma, or mucinous carcinoma 
2. Depth of submucosal invasion >1000 μm 
3. Vascular invasion is positive 
4. Grade 2/3 budding 
In classifying the histological type of a carcinoma, the predominant pattern is adopted as its 
representative histological type in the Japanese classification of colorectal carcinoma 
(Sugihara, 2009). For example, for a tumor consisting mainly of well-differentiated 
carcinoma with a small portion of moderately differentiated carcinoma, a diagnosis of “well-
differentiated carcinoma” should be made. High-grade carcinomas that are poorly 
differentiated adenocarcinomas, signet ring cell adenocarcinomas, or mucinous carcinomas 
have strong proliferative and metastatic capabilities.  
When it is possible to identify the muscularis mucosae, the depth of submucosal invasion is 
the distance between the deepest edge of the muscularis mucosae and the deepest invasion. 
If the muscularis mucosae cannot be identified, the depth of submucosal invasion is the 
distance between the surface of the tumor and the deepest invasion. In Ip lesions with 
disrupted muscularis mucosae, the depth of submucosal invasion is the distance between 
the deepest invasion and the reference line, and it is defined as the boundary between the 
tumor head and the pedicle. When cancer does not invade beyond the reference line, it is 
defined as head invasion (Fig. 11). According to Kitamura, for pedunculated SM cancer, the 
rate of lymph node metastasis was 0% in cases of head and stalk invasion with depths <3000 
μm if lymphatic invasion was not observed. For nonpedunculated SM cancer, the rate of 
lymph node metastasis was also 0% if SM depth was <1000μm (Kitajima, 2004). 
 
 
   mm, muscularis mucosae; mp, muscularis propria 
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Vessel invasions contain 2 types of lymphatic invasion and venous invasion. The distinction 
is not so easy. When cancer nests are located in lymphatic ducts lined by flat endothelial 
cells, it is considered positive lymphatic invasion. Cancer nests existing near an artery are 
very likely to represent venous invasion, which can be confirmed by determining the 
presence of an internal elastic membrane and plain muscle around the cancer nests. 
Occasionally, it is difficult to detect venous invasion by hematoxylin and eosin staining. 
Elastica van Gieson staining, however, is useful for detecting venous invasion.  
Budding is defined as cancer nests comprising less than 5 cancer cells and invading the 
interstitial tissue of the cancer growth front. The area where budding appears most 
frequently is selected and the number of instances is counted in a ×200 field. Budding is 
classified into 3 groups (grade 1, 0–4 pieces; grade 2, 5–9 pieces; and grade 3, ≥10 pieces), 
and grades 2 and 3 are risk factors for lymph node metastasis.  
2.6 Differential diagnosis   
There are many diseases that must be differentiated from colorectal carcinoma. The 
characteristic appearance of colorectal carcinoma does not cause interpretive difficulties 
generally.  
Metastatic lesions in the large intestine: Cancers that frequently metastasize to the large 
intestine include those of the stomach, pancreas, ovaries, lung, and breasts in descending 
order of frequency. The endoscopic appearance of metastatic lesions generally includes (1) 
extraluminal masses with or without hyperemia, (2) wall thickening, and (3) hyperemia. 
Extraluminal masses are often smooth, but the base is not distinct. Mucosal hyperemias 
are often multiple, and the border is obscure. Ulcerated tumors are also the findings of 
metastatic lesions, but the marginal elevation typical of primary cancers is rarely observed 
(Fig. 12A). 
Peritonitis carcinomatosa: Peritonitis carcinomatosa does not affect the mucosal surface.  
Malignant lymphoma and sarcoma: Polypoid-type lymphomas are often smooth-surfaced. 
Colon cancer ulcers are usually accompanied by irregular margins, but that of ulcerative-
type malignant lymphoma often contains a smooth margin (Fig. 12B, C). Sarcomas are likely 
to be malignant lymphomas. 
 
 
(A) (B) (C) (D) 
A, metastatic colon cancer from gastric cancer (poorly differentiated adenocarcinoma);  
B, ulcerative type of malignant lymphoma; C, elevated type of malignant lymphoma;  
D, carcinoid 
Fig. 12. Colorectal neoplasmas  
Carcinoids: Carcinoids are covered with the normal mucosa initially. In addition, carcinoids 
are usually elastic, hard, and yellowish. Endoscopic ultrasound staging (EUS) is useful for 
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diagnosing the internal state and present layer. If they invade mucosa, vessels and ulcer 
formation occur (Fig.12D) 
Inflammatory disease: Inflammatory colonic diseases, such as Crohn disease (CD), 
ulcerative colitis (UC), and colonic tuberculosis (TBc), are sometimes likely to resemble 
colonic carcinoma regarding its endoscopic features. CD often includes longitudinal 
ulceration, but the ulcer is sharp and smooth. UC is rarely displayed as a self-limited ulcer, 
but ulcers of UC are soft and thin. Colonic TBc is rarely similar to Type 2 cancer, but the 
ulcers of TBc are not hard or irregular.  
3. Endoscopic treatment for colorectal carcinoma and its precursors  
There are many methods of treating colorectal tumors, such as hot biopsy and snare 
polypectomy, EMR, EPMR, and ESD. Advances in endoscopic instruments and techniques 
have led to a large increase in the number of endoscopically resected lesions. Safe and 
reliable endoscopic treatment for colorectal carcinoma requires diagnostic ability and skill in 
colonoscopy. 
3.1 Hot biopsy and polypectomy 
Colonic polyps less than 0.8 cm in diameter are usually removed by hot biopsy, particularly 
when they are sessile, whereas polyps more than 0.8 cm in diameter are usually removed by 
snare polypectomy, particularly when they are pedunculated (Mann, 1999). Hot biopsy 
involves grasping the top part of the polyp upward and moderately cauterizing the polyp. 
Hot biopsy is performed cautiously in the cecum using a low amplitude and brief duration 
of current because the colonic wall is the thinnest and most vulnerable to transmural 
necrosis in this region (Weston, 1995). One limitation of hot biopsy is that only a portion of 
the polyp can be examined pathologically because the polyp cannot be completed removed. 
Therefore, we also perform snare polypectomy for even polyps smaller than 0.8 cm in 
diameter.  
Snare polypectomy is chiefly applied to pedunculated and sessile lesions of 0.5 to 2.0 cm in 
diameter. Sessile polyps between 2 and 3 cm in diameter may be removed by snare 
polypectomy after creating a pseudopedicle by injecting normal saline or other solution into 
the polyp base, as described in the following section (Waye, 1997; Kato, 2001, 2008). Sessile 
polyps more than 3 cm in diameter may be unamenable to conventional snare polypectomy 
but can be removed by sequential piecemeal polypectomy over several colonoscopies 
(Dell’Abate, 2001).  
The complication rate of therapeutic colonoscopy is 1.4–2.0% (Jentschura, 1994; Nelson, 
2002; Kato, 2008). The most common postpolypectomy complications are gastrointestinal 
bleeding, colonic perforation, and local peritonitis. In local peritonitis, a patient develops 
abdominal pain, leukocytosis, and localized peritoneal irritation from an almost transmural 
burn occurring during polypectomy. This occurs in up to 1% of polypectomies (Waye, 1996). 
This syndrome is usually managed medically by the cessation of oral intake, intravenous 
hydration, and antibiotic administration (Waye, 1993). 
3.2 EMR and EPMR 
EMR combines the classic principles of conventional snare polypectomy with submucosal 
injection to remove more deeply affected mucosa or submucosa by resecting the lesion 
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through the middle or deep submucosa. It is a less invasive treatment option for colorectal 
lesions even if the lesion is flat and difficult to remove by snare polypectomy. When we 
want to resect early colorectal carcinoma surrounded by the normal mucosa, EMR is a 
suitable procedure. After observation of the lesion, hypertonic saline solution with 
epinephrine is injected into the submucosal layer. At this time, the lesion-lifted condition is 
observed as follows (see section 3.3). When the lifted condition is complete, the bulging lesion 
is captured in a surgical snare and removed by cauterization with a high-frequency current.  
A lesion less than 2.0 cm in diameter can generally be resected en bloc. The relationship 
between tumor size and the en bloc resection rate in our medical center between 2000 and 
2010 is presented in Fig. 13. Lesions smaller than 20 mm in diameter were resected en bloc in 
more than 90% of colorectal carcinoma cases. Most lesions larger than 26 mm in diameter 
are treated by the piecemeal method.  
 
Fig. 13. Relationship between lesion size and en bloc resection (EMR) vs. EPMP  
Among 281 cases of early colorectal carcinomas treated by EMR, only 2 cases recurred 
during the observation period of 5 years (recurrence rate, 0.8%). The recurrent cases could 
be retreated by endoscopic methods. Conversely, 8 cases among 148 cases treated by EPMR 
recurred (recurrence rate, 5.4%), and 2 of these cases were treated surgically. Therefore, the 
recurrence rate of EMR is significantly lower than that of EPMR (p<0.01). However, these 
methods are used to treat lesions of different sizes, and thus, simple comparisons of 
recurrence rates can be misleading. However, we believe that en bloc resection is better than 
piecemeal resection from the point of view of accurate pathological diagnosis. Large 
superficial carcinomas without lymph node metastasis requiring en bloc resection are 
currently resected using ESD at our medical center.  
Bergmann (2003) reported that local recurrence after EMR was observed in 2 of 59 
completely resected adenomas and in 0 of 6 early-stage carcinomas during a mean follow-
up of 18 months. He concluded that advanced non-polypoid colorectal adenomas and early-
stage carcinomas can be safely and effectively resected by EMR.  
Jin et al. (2009) reported that recurrence was found to be related to piecemeal resection and 
diameters larger than 20 mm and that >20-mm-diameter is an independent risk factor for 
laterally spreading tumors (LSTs) treated by EMR. They stated that for the LSTs larger than 
20 mm in diameter, another method, such as ESD or even a major operation, should be 
considered. 
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3.3 Classification of lesion-lifted condition  
Special findings such as depression, ulceration, fold convergence, bleeding tendency, 
irregular shape, and a non-lifting sign indicate a deep invasion (Uno, 1994; Kobayashi, 
2007). The “non-lifting sign” is a simple yes/no classification, and compared to EUS, it is a 
much easier method to determine whether EMR is indicated. However, because it is by no 
means rare for submucosal invasion to be found among lesions that exhibit a negative lifting 
sign, we have created a more detailed classification of the lesion-lifted condition. In a 
previous study, we focused on the tumor’s lifted condition after submucosal injection and 
classified lesions into 4 types (Kato, 2001).  
 
Fig. 14. Classification of the lesion-lifted condition (Kato, 2001)  
This classification is closely related to the depth of invasion, and has proved to be 
particularly useful in the identification of early colorectal cancers that are good candidates 
for endoscopic treatment without requiring any special apparatus. We classified the lesion-
lifted condition at the time of submucosal fluid injection into 4 categories (Fig. 14): (1) 
completely lifted/soft (CLS), (2) completely lifted/hard (CLH), (3) incompletely lifted (ICL), 
and (4) non-lifting (NL). A CLS lesion is completely lifted by submucosal injection, and it 
stretches softly like a dome. A CLH lesion is completely lifted, but it is rigid and maintains its 
original form. An ICL lesion is slightly lifted, but the surrounding mucosa lifts higher than the 
lesion. An NL lesion is not lifted, and only the surrounding mucosa is elevated (Fig. 15). 
 
    CLS             CLH             ICL                           NL 
Fig. 15. Classification of the lesion-lifted condition (Kato, 2001)  
Lesion-lifted conditions are related to tumor pathology and the extent of tumor invasion, 
and they often correspond to particular macroscopic types of tumors. The relationship 
between the lifted condition and macroscopic type is shown in Table 1. Type IIa 
predominates among CLS lesions, whereas elevated lesions such as types Ip, Isp, and Is tend 
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to fall into the CLH category. On the other hand, type IIa+IIc is relatively common type of 
morphology among ICL and NL lesions. The relationship between lifted conditions from 
CLS to ICL lesions and their corresponding macroscopic types are statistically significant 
(p<0.001). 
 
 Ip Isp Is IIa IIc IIa+IIc LST 
CLS 4 30 66 324 24 9 105 
CLH 25 73 90 77 13 8 18 
ICL 0 10 22 21 7 12 13 
NL 0 0 8 2 1 5 2 
Table 1. Relationship between lifted condition and macroscopic type (p<0.001) 
Classification of submucosal invasion is based on the division of the submucosa into 3 layers 
from sm1 to sm3. sm1, sm2, and sm3 are lesions that are limited to the upper, middle, and 
lower thirds of the submucosal layer, respectively. sm1 lesions are further subdivided into 3 
categories (a, b, and c) with regard to the degree of horizontal involvement of the upper 
submucosal layer (ratio of involved part and non-involved part). Whereas sm1a+sm1b 
lesions have a very low risk for metastasis, the malignant potential increases with increasing 
depth of submucosal invasion (Kudo, 1997; Kashida, 2006). The relationship between the 
lesion-lifted condition and the depth of invasion is shown in Table 2. We used Kudo’s 
classification to subclassify the depth of SM cancer. All CLS lesions are found to be sm1 or 
shallower, whereas the CLH category included 20 sm2 and 14 sm3 lesions. The rate of SM 
massive cancer (sm2 or sm3) among CLH lesions was 11.0%. ICL lesions range from sm1 to 
sm3, and most of the NL lesions exhibit invasion to sm3 or deeper. Four noncancerous cases 
and 1 mucosal cancer case of NL lesions were recurred adenomas and cancers that had 
previously been treated by endoscopic therapy. The rates of SM massive cancer among ICL 
and NL lesions are 38.5% and 74.1%, respectively. The lesion-lifted condition well correlates 
with the depth of invasion. 
 
 nc cia m sm1 sm2 sm3- 
CLS 451 65 34 3 0 0 
CLH 123 75 58 18 20 14 
ICL 20 14 7 7 10 20 
NL 4 0 1 0 1 13 
nc, noncancerous lesion; cia, cancer in adenoma; m, mucosal cancer; sm1, shallow SM cancer;  
sm2, moderate SM cancer; sm3, deep SM cancer 
Chi-square test, p < 0.0001 
Table 2. Relationship between the lesion-lifted condition and the depth of invasion (Number 
of the lesions) 
When the lifted condition of a lesion is CLS or CLH, it is a good indication that endoscopic 
resection will be successful. When the lifted condition is ICL, however, endoscopic resection 
has a smaller chance of success. And almost all of NL lesion without previous endoscopic 
therapy had better receive surgical treatment.  
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3.4 ESD 
ESD is a resection technique for superficial neoplastic lesions of the gastrointestinal tract 
without the use of snaring. It was developed for en bloc resection of large superficial 
mucosal tumors, and it was initially used in the stomach and later in the esophagus, colon, 
and rectum. ESD is superior to EMR for a more reliable en bloc resection of a targeted area 
of the mucosa. It also provides a higher complete resection rate with a lower recurrence rate 
compared with EPMR (Saito, 2010). The drawbacks of ESD include that it is a time-
consuming procedure, has greater technical demands, and has a higher rate of perforation. 
For these reasons, ESD for colorectal tumor is performed as an advanced medical treatment 
because it is currently not recognized as treatment covered by the national health insurance 
system of Japan in 2011.  
3.4.1 Method of ESD  
Method of ESD is incising mucosa around a lesion lifted by injected fluid and dissecting the 
submucosal space under the lesion (Fig.16). ESD for colorectal tumors is considered more 
technically demanding than ESD in the stomach for a variety of reasons including the 
following: (1) the colonic wall is thinner and softer than the gastric wall; (2) endoscopic 
control is difficult in some parts of the colon because of its meandering form; and (3) there 
are limitations in the retroflex approach due to the narrow lumen of the colon, and tumors 
can be located on or behind a prominent fold of the colon. 
 
 
Fig. 16. Method of ESD 
First, the borders of the tumors are determined by chromoendoscopy with indigo carmine 
spraying for enhanced or magnified observation using NBI. Marking around the tumor is 
not necessary in most cases because colorectal neoplasms typically have clear margins. 
The use of 0.4% sodium hyaluronate solution for submucosal injection keeps the tumor 
lifted for long periods (Yamamoto, 1999). For successful ESD, the position of the patient 
should be selected such that the lesion is located at the top of the colonic lumen with regard 
to gravity. Because the lesion is naturally pulled down and blood flows down from the 
bleeding point by gravity, good visualization of submucosal space can be maintained.  
Next, the mucosal incision in front of the tumor is made with a short needle knife such as 
FlushKnife BTTM (1.5 mm; Fujifilm Corp., Tokyo, Japan) (Fig.17). Only the needle part 
should be used for the incision, keeping the tip of the sheath touching the surface of the 
mucosa without pushing the sheath into the submucosal layer. We use the endcut mode of 
electric surgical unit for the mucosal incision. After repeated submucosal injection, 
submucosal dissection is performed parallel to the muscular layer by sliding the knife from 
the center to the side while hooking submucosal fibers with the knife. We use the swift 
coagulation mode of electric surgical unit at this time. When thick vessels can be observed in 
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the submucosal layer, grasping and soft coagulation are performed using coagulation 
forceps. Furthermore, a surrounding incision is made, and submucosal dissection is 
performed while lifting up the dissected part of the tumor with the edge of the transparent 
cap at the tip of the scope. Finally, hemostasis and the lack of a weak point of the muscularis 
propria are confirmed after resection. 
 
 
(1) (2) (3) (4) 
(5) (6) (7) (8) 
Fig. 17. ESD using FlushKnife BTTM for rectal mucosal carcinoma of 80mm in diameter 
The usefulness of new grasping-type scissor forceps (GSF) such as ClutchCutter™ (Fujifilm 
Corp., Tokyo, Japan) was reported by Akahoshi et al. (2010). ESD using GSF is a safe (no 
intraoperative complication) and technically efficient (curative en bloc resection rate, 92%) 
method for the dissection of early gastrointestinal tumors. The use of GSF is a promising 
option for performing ESD in early-stage GI tract tumors both safely and effectively. We 
typically use GSF on the lesions that are difficult to approach or control by endoscopy. The 
ability to confirm that GSF is not grasping the muscle layer before coagulation or cutting is a 
point of safety (Fig.18). 
 
 
Fig. 18. ESD using Clutchcutter™ (Fujifilm Corp., Tokyo, Japan) 
3.4.2 Cases of ESD 
We investigated 116 patients with colorectal lesions for whom ESD was performed between 
Jan 2005 and Mar 2011. The tumors were entirely located in the large intestine (27 in the 
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transverse colon and 25 in the rectum) (Table 3). Type IIa was the most common 
macroscopic type (Table 4). The average diameter was approximately 30 mm (range, 4–82 
mm). The average operation time was 75 min. Regarding complications, an incision in the 
muscularis propria was found in 6% cases. Perforation was experienced in 7%. But all of the 
perforation hole could be closed by endoscopic clip without surgical procedure.   
Approximately half the lesions were adenomas, and the rest were carcinomas. One patient 
with carcinoma in situ exhibited recurrence in the mucosa and received endoscopic 
treatment. Additional colectomy was performed in 8 patients with submucosal invasion. 
There are pathologicalresidual cancer nests in 2 cases. One patient had persistent carcinoma 
in the colonic wall, and another had lymph node metastasis. 
 
 C A T D S R 














C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon; R, rectum 
Table 3. location of the ESD lesions 
 
 Is IIa IIc SMT 










SMT, submucosal tumor 
Table 4. Macroscopic types of ESD lesions 
3.4.3 Comparisons among EMR, EPMR and ESD 
Clinicopathological data were compared among EMR, EPMR, and ESD between 2000 and 2011. 
The size in diameter of the lesions that were treated by each technique was compared. Very large 
lesions can be treated by EPMR and ESD. The mean sizes of lesions treated by EMR, EPMR, and 
EMR were 13.1 (range, 2–45), 24.6 (4–69), and 29.7 mm (4–82), respectively (Fig. 19).  
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The mean operation times of the 3 methods were also compared. ESD required about 75 
minutes to perform and longer than the other techniques. Regarding ESD complications, 
postoperative hemorrhage is not frequent, but perforation and muscularis propria incision 
are more common with ESD than with EMR or EPMR. However, all perforations and 
muscle incisions could be closed by endoscopic clipping, and there was no negative effect in 








Postoperative hemorrhage:  
endoscopic hemostasis 
16(1.5%) 6(4.1%) 3(2.6%) 
Perforation: endoscopic closure 1(0.1) 0 8(6.9) 
Perforation: surgical closure 1(0.1) 0 0 
Incision of muscularis propria:  
endoscopic clipping 
0 0 7(6.0) 
Local peritonitis: conservative therapy 2(0.2) 2(1.4) 2(1.7) 
Table 5. Complications of endoscopic treatments for colorectal tumor 
Colorectal ESD can be performed in all sites of the large intestine, and even a large lesion 
could be resected en broc using ESD. However, the procedure was lengthy and involved 
more complications than did other treatments. Further technical proficiency and 
instrumental improvements are expected in the future.  
4. Conclusions 
New methods of endoscopic diagnosis and treatment have been recently developed. 
Patients with early-stage colorectal carcinoma can be diagnosed by colonoscopy. Endoscopic 
treatment facilitates healing, and the method is less invasive, more cost-effective, and less 
time-consuming for patients. Endoscopic apparatuses, devices, and techniques must be 
further improved in the near future. Endoscopy for colorectal carcinoma will remain 
important in medical education and practice. 
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